BOSTON (Dow Jones) -- Boston Scientific reported higher fourth-quarter earnings early Tuesday, largely due to large charges taken the previous year related to stock options and the repatriation of foreign profits.
http://c.moreover.com/click/here.pl?r464307583
http://c.moreover.com/click/here.pl?r464307583